Clinical Trials
122 trialsA Study of sEphB4-HSA in Kaposi Sarcoma
Vasgene Therapeutics, Inc
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Henan Cancer Hospital
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma
The First Affiliated Hospital of Xinxiang Medical College
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
Chidamide Combined With Toripalimab in Sarcoma
Sun Yat-sen University
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Sun Yat-sen University
ISAC
Heidelberg University
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
Tucidinostat Plus Apatinib for Advanced Osteosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PROACH
Ruijin Hospital
FIBROSARC US
Philogen S.p.A.
IntriNSiC
Philogen S.p.A.
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma
Sun Yat-sen University
ALT GIST
Australasian Gastro-Intestinal Trials Group
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma
Sun Yat-sen University
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
HyperTET
Ludwig-Maximilians - University of Munich
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Relyage
Centre Hospitalier Universitaire, Amiens
Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma
Peking University Cancer Hospital & Institute
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Ruijin Hospital
Irinotecan and Temozolomide for Ewing Sarcoma
Peking University People's Hospital
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Sun Yat-sen University
KAPVEC
Assistance Publique - Hôpitaux de Paris
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Fudan University
COPELIA
University of Manchester
Fruquintinib in the Treatment of Soft Tissue Sarcoma
Fudan University
Nivolumab for Recurrent/Metastatic Carcinosarcoma
Yonsei University
A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer
Hutchmed
A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
DOREMY
The Netherlands Cancer Institute
Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)
Genor Biopharma Co., Ltd.
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Fudan University
SINDIR
Maria Sklodowska-Curie National Research Institute of Oncology
UN-RESARC
Maria Sklodowska-Curie National Research Institute of Oncology
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
Sun Yat-sen University
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Fudan University
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
ChineseAMS
COWBOY
Radboud University Medical Center
MAPAC
Peking University People's Hospital
PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS
Fudan University
Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Sun Yat-sen University